France
· Delayed Price · Currency is EUR AB Science Statistics
Total Valuation
AB Science has a market cap or net worth of EUR 53.56 million. The enterprise value is 63.40 million.
| Market Cap | 53.56M |
| Enterprise Value | 63.40M |
Important Dates
The next estimated earnings date is Monday, April 28, 2025.
| Earnings Date | Apr 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AB Science has 65.16 million shares outstanding. The number of shares has increased by 9.19% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 65.16M |
| Shares Change (YoY) | +9.19% |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | 31.40% |
| Owned by Institutions (%) | 1.01% |
| Float | 21.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 39.29 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.49 |
| EV / Sales | 58.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -14.11 |
Financial Position
The company has a current ratio of 0.82
| Current Ratio | 0.82 |
| Quick Ratio | 0.78 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.22 |
| Interest Coverage | -7.04 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -18.16% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 27,050 |
| Profits Per Employee | -151,075 |
| Employee Count | 57 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 0.65 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.21% in the last 52 weeks. The beta is 1.18, so AB Science's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | -70.21% |
| 50-Day Moving Average | 0.97 |
| 200-Day Moving Average | 1.54 |
| Relative Strength Index (RSI) | 24.77 |
| Average Volume (20 Days) | 38,751 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AB Science had revenue of EUR 1.08 million and -6.04 million in losses. Loss per share was -0.12.
| Revenue | 1.08M |
| Gross Profit | 825,000 |
| Operating Income | -8.16M |
| Pretax Income | -6.04M |
| Net Income | -6.04M |
| EBITDA | -8.58M |
| EBIT | -8.16M |
| Loss Per Share | -0.12 |
Balance Sheet
The company has 9.13 million in cash and 18.96 million in debt, giving a net cash position of -9.84 million or -0.15 per share.
| Cash & Cash Equivalents | 9.13M |
| Total Debt | 18.96M |
| Net Cash | -9.84M |
| Net Cash Per Share | -0.15 |
| Equity (Book Value) | -24.60M |
| Book Value Per Share | -0.42 |
| Working Capital | -3.15M |
Cash Flow
In the last 12 months, operating cash flow was -4.24 million and capital expenditures -251,000, giving a free cash flow of -4.49 million.
| Operating Cash Flow | -4.24M |
| Capital Expenditures | -251,000 |
| Free Cash Flow | -4.49M |
| FCF Per Share | -0.07 |
Margins
| Gross Margin | 76.25% |
| Operating Margin | -754.25% |
| Pretax Margin | -557.76% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -415.25% |
Dividends & Yields
AB Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.19% |
| Shareholder Yield | -9.19% |
| Earnings Yield | -14.21% |
| FCF Yield | -8.39% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |